Jung-Hsin Lin

Dr. Jung-Hsin Lin

Biomedical Translation Research Center & Research Center for Applied Sciences, Academia Sinica, No. 128 Academia Rd. Sec. 2, Nankang, Taipei 11529, Taiwan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2002 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
JLJung-Hsin Lin
Jung-Hsin Lin
APAlexander L. Perryman
Alexander L. Perryman
JSJulie R. Schames
Julie R. Schames
JMJ. Andrew McCammon
J. Andrew McCammon


1 April 2008 in Cancer Research
Verified
Journal Article
Closed access
PDF file
YLYi-Chu Lin
Yi-Chu Lin
JLJung-Hsin Lin
Jung-Hsin Lin
CCChia-Wei Chou
Chia-Wei Chou
YCYu-Fan Chang
Yu-Fan Chang
SYShu-Hao Yeh
Shu-Hao Yeh
CCChing-Chow Chen
Ching-Chow Chen
Statins are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors broadly used for the control of hypercholesterolemia. Recently, they are reported to have beneficial effects on certain cancers. In this study, we show that statins inhibited the histone deacetylase (HDAC) activity and increased the accumulation of acetylated histone-H3 and the expression of p21WAF/CIP in human cancer cells. Computational modeling showed the direct interaction of the carboxylic acid moiety of statins with the catalytic site of HDAC2. In the subsequent enzymatic assay, it was shown that lovastatin inhibited HDAC2 activity competitively with a Ki value of 31.6 μmol/L. Sp1 but not p53 sites were found to be the statins-responsive element shown by p21 luciferase-promoter assays. DNA affinity protein binding assay and chromatin immunoprecipitation assay showed the dissociation of HDAC1/2 and association of CBP, leading to the histone-H3 acetylation on the Sp1 sites of p21 promoter. In vitro cell proliferation and in vivo tumor growth were both inhibited by statins. These results suggest a novel mechanism for statins through abrogation of the HDAC activity and promoter histone-H3 acetylation to regulate p21 expression. Therefore, statins might serve as novel HDAC inhibitors for cancer therapy and chemoprevention. [Cancer Res 2008;68(7):2375–83]

25 November 2002 in Biopolymers
Verified
Journal Article
Closed access
PDF file
JLJung-Hsin Lin
Jung-Hsin Lin
APAlexander L. Perryman
Alexander L. Perryman
JSJulie R. Schames
Julie R. Schames
JMJ. Andrew McCammon
J. Andrew McCammon

30 May 2012 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JWJui-Chih Wang
Jui-Chih Wang
PCPei-Ying Chu
Pei-Ying Chu
CCChung-Ming Chen
Chung-Ming Chen
JLJung-Hsin Lin
Jung-Hsin Lin
Identification of possible protein targets of small chemical molecules is an important step for unravelling their underlying causes of actions at the molecular level. To this end, we construct a web server, idTarget, which can predict possible binding targets of a small chemical molecule via a divide-and-conquer docking approach, in combination with our recently developed scoring functions based on robust regression analysis and quantum chemical charge models. Affinity profiles of the protein targets are used to provide the confidence levels of prediction. The divide-and-conquer docking approach uses adaptively constructed small overlapping grids to constrain the searching space, thereby achieving better docking efficiency. Unlike previous approaches that screen against a specific class of targets or a limited number of targets, idTarget screen against nearly all protein structures deposited in the Protein Data Bank (PDB). We show that idTarget is able to reproduce known off-targets of drugs or drug-like compounds, and the suggested new targets could be prioritized for further investigation. idTarget is freely available as a web-based server at http://idtarget.rcas.sinica.edu.tw.

1 June 2007 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
RARommie E. Amaro
Rommie E. Amaro
DMDavid D. L. Minh
David D. L. Minh
LCLily S. Cheng
Lily S. Cheng
WLWilliam M. Lindstrom
William M. Lindstrom
AOArthur J. Olson
Arthur J. Olson
JMJ. Andrew McCammon
J. Andrew McCammon